Norton P. Peet

Emergent BioSolutions (Canada) — Canada

Chemistry · Physical Sciences

41h-index5.5kcitations308works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Synthesis and Biological Evaluation(44), Phenothiazines and Benzothiazines Synthesis and Activities(39), Synthesis and Characterization of Heterocyclic Compounds(36), Synthesis and Reactions of Organic Compounds(32), Chemical Synthesis and Analysis(27)

Publications307 total

Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of Henipaviruses
Journal of Medicinal Chemistry·2026
Discovery and Characterization of 7,8-Dihydropyrido[4,3-d]pyrimidines as SARS-CoV-2 Entry Inhibitors
Drugs and Drug Candidates·2025Open Access
Discovery and Optimization of First-in-Class Furopyrimidine-based Inhibitors of Henipaviruses
2025
Corrigendum to “Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses” [Europ. J. Med. Chem. 2925 (2025) 117679]
European Journal of Medicinal Chemistry·2025
Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses
European Journal of Medicinal Chemistry·2025· 8 citedOpen Access
Guardians at the Gate: Optimization of Small Molecule Entry Inhibitors of Ebola and Marburg Viruses
Journal of Medicinal Chemistry·2024· 4 citedOpen Access
N-Substituted Pyrrole-Based Heterocycles as Broad-Spectrum Filoviral Entry Inhibitors
Journal of Medicinal Chemistry·2024· 5 citedOpen Access
CCDC 2156558: Experimental Crystal Structure Determination
The Cambridge Structural Database·2022Open Access
Synthesis, Optimization, and Structure–Activity Relationships of Imidazo[1,2-<i>a</i>]pyrimidines as Inhibitors of Group 2 Influenza A Viruses
Journal of Medicinal Chemistry·2022· 25 cited
Evidence for distinct mechanisms of small molecule inhibitors of filovirus entry
PLoS Pathogens·2021· 30 citedOpen Access
Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutinins
Antiviral Research·2021· 25 citedOpen Access
Discovery and Structural Optimization of 4-(Aminomethyl)benzamides as Potent Entry Inhibitors of Ebola and Marburg Virus Infections
Journal of Medicinal Chemistry·2020· 30 citedOpen Access
Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus
Antiviral Research·2020· 20 citedOpen Access
Optimization of 4-Aminopiperidines as Inhibitors of Influenza A Viral Entry That Are Synergistic with Oseltamivir
Journal of Medicinal Chemistry·2020· 27 citedOpen Access
Influenza Virus: Small Molecule Therapeutics and Mechanisms of Antiviral Resistance
Current Medicinal Chemistry·2018· 89 citedOpen Access
Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus Disease
Current Medicinal Chemistry·2017· 9 cited
Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor
Antiviral Research·2017· 31 citedOpen Access
DNA Targeting as a Likely Mechanism Underlying the Antibacterial Activity of Synthetic Bis-Indole Antibiotics
PMC·2016
DNA Targeting as a Likely Mechanism Underlying the Antibacterial Activity of Synthetic Bis-Indole Antibiotics
Antimicrobial Agents and Chemotherapy·2016· 26 citedOpen Access
Synthesis of new heterocyclic analogs of linezolid
Tetrahedron Letters·2015· 4 cited
page 1 of 16Next →

Frequent Co-authors

Terry L. Bowlin(17), John D. Williams(14), Donald T. Moir(12), Michelle M. Butler(8), Philippe Bey(7), Michael R. Angelastro(5), Joseph P. Burkhart(5), Sina Bavari(5), Shyam Sunder(5), Son T. Nguyen(4), Daniel Andrew Aiello(4), Rekha G. Panchal(4), Herbert O. House(3), Timothy J. Opperman(3), Steven M. Kwasny(3), Shujaath Mehdi(3), Helena Majgier-Báranowska(3), Steven C. Cardinale(3), Lijun Rong(3), Xiaoyuan Ding(3)